This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Compact view
Research pass: stub-manual Compound SKIP-FOR-NOW HIGH

Salbutamol

Extended Research
High-risk compound

Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.

Extended Research

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

Editor's verdict SKIP-FOR-NOW HIGH

For a non-asthmatic, no biohacking case. The "salbutamol as mini-clenbuterol" gray-market use is occasional in bodybuilding circles, but the short half-life means impractically frequent dosing for sustained lipolytic effect, and the cardiac stimulation profile (tachycardia, tremor, hypokalemia at high dose) is real. For a tested combat athlete, the WADA permitted-inhaler-threshold makes it usable for legitimate asthma — but exceeding the threshold (even via nebulizer or stacking inhalers) has produced WADA failures. Verdict flips to STANDARD-OF-CARE for documented exercise-induced bronchoconstriction with a TUE; SKIP-FOR-NOW otherwise.

Research pass: stub-manual
Verdict change log
  • 2026-06-05 — Initial verdict SKIP-FOR-NOW. No asthma indication; gray-market lipolytic case too weak vs clenbuterol. (stub)

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…